Evidence review

BPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evidence Review

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-kpv-ibd-crohns-colitis`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-kpv-ibd-crohns-colitis

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-kpv-ibd-crohns-colitis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-kpv-ibd-crohns-colitis/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-kpv-ibd-crohns-colitis/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-kpv-ibd-crohns-colitis/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: KPV is studied for gut lining and inflammatory gut pathways — mucosal repair vs ongoing gut degeneration.

Why BPC-157 might help you

  1. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  2. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  3. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why KPV might help you

  1. Repair pathway: KPV is studied for gut lining and inflammatory gut pathways — mucosal repair vs ongoing gut degeneration.
  2. Therefore for you: If that layer is part of your problem, KPV is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Each compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.

  • BPC-157 → structure / tissue
  • KPV → gut / localized anti-inflammatory

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 17
  • Claims tagged human evidence: 7
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 31
  • Reddit posts catalogued: 27
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 3
  • Total sources in chain: 47

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

STABLE GASTRIC PENTADECAPEPTIDE BPC 157 HEALS CYSTEAMINE-COLITIS AND COLON-COLON-ANASTOMOSIS (source s1)

Rat study showing BPC-157 healing in colitis/anastomosis model.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease (source s2)

Murine colitis models with KPV anti-inflammatory outcomes.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

S808 Oral Peptide BPC-157—An Emerging Adjunct to... (source s3)

Notes preclinical focus and lack of clinical data for BPC-157 in GI contexts.

Evidence type: Published research.

Peptide-based therapeutic and delivery strategies for inflammatory bowel disease (source s4)

2025 review covering peptide therapies including BPC-157 for IBD management.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

KPV Peptide and Ulcerative Colitis (source s7)

Medical blog on KPV + BPC-157 combination for UC/IBD gut repair.

Evidence type: Published research.

BPC-157 vs KPV: Which Gut Healing Peptide Is Better? (2026) (source s8)

2026 comparison review of BPC-157 and KPV for gut/IBD conditions.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

State-of-the-art Ulcerative Colitis Treatment (source s9)

Discusses BPC-157 for UC and Crohn's, notes synergy potential with KPV for gut repair and inflammation control in functional medicine context.

Evidence type: Published research.

The Benefits of Peptides: BPC157 & KPV for Healing and Gut Health (source s10)

Reviews BPC-157 for tissue repair and KPV for anti-inflammatory effects in IBD/colitis models; highlights their complementary use for gut health.

Evidence type: Published research.

Anti‐Inflammatory Peptides as Promising Therapeutics Agent ... (source s11)

2025 review on anti-inflammatory peptides including potential for IBD treatment.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Peptide Therapy for Gut Healing: The Role of BPC-157 and KPV (source s13)

Blog post on BPC-157 and KPV combination for IBD, colitis, and intestinal repair.

Evidence type: Published research.

Best Peptides for Gut Health: BPC-157, KPV, Larazotide & ... (source s20)

Discusses combination of BPC-157 and KPV for gut repair in IBD/Crohn's/ulcerative colitis contexts, published Jan 2025.

Evidence type: Published research.

Best Peptides for Gut Health: BPC-157 and KPV | AWP (source s21)

2026 article on oral BPC-157 + KPV for gut repair and IBD-related issues.

Evidence type: Published research.

Regeneration or Risk? A Narrative Review of BPC-157 for ... (source s22)

2025 narrative review covering BPC-157 regenerative effects, relevant to gut/IBD applications.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157 (source s24)

2012 review highlighting BPC-157's potential in IBD/ulcerative colitis therapy from animal models, early phase II trials, wound healing, and safety profile.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

BPC-157 Ulcerative Colitis | Healing the Gut (source s25)

Discusses preclinical research on BPC-157 and KPV for gut inflammation, ulcerative colitis, and IBD; notes limited human data and complementary roles in repair vs. anti-inflammation.

Evidence type: Published research.

The Gut-Brain-Peptide Axis: How BPC-157 and KPV Are Emerging in Neurological and Gut Health Research (source s26)

2026 article on BPC-157 and KPV mechanisms for IBD/colitis and gut-brain axis; references 2023 Nature study on KPV nanoparticles in colitis models and complementary actions with BPC-157.

Evidence type: Published research.

KPV Peptide: Comprehensive Guide to Benefits, Dosage and ... (source s27)

May 2026 guide on KPV for colitis/IBD, anti-inflammatory effects, PepT1 interaction, and animal models of ulcerative colitis; notes synergy potential with BPC-157.

Evidence type: Published research.

What people say on Reddit

Peptide Research for Crohn's Disease — Reddit, r/PeptidePathways (source s5)

User anecdotes and discussion of BPC-157 + KPV combo for Crohn's/colitis in DSS mouse model and personal use.

Considering My Options — Reddit, r/UlcerativeColitis (source s12)

User anecdote describing personal use of BPC-157 + KPV for UC alongside mesalamine, with mixed results and consideration of biologics.

Anyone here with experience using KPV or other peptides for Crohn's disease? — Reddit, r/Biohackers (source s14)

User reports KPV worked great for brother's Crohn's; another notes biggest impact from oral BPC157 and KPV; positive experience with KPV subq for inflammation and bowel movements.

Any tried BPC 157 peptides? — Reddit, r/UlcerativeColitis (source s15)

User planning or using BPC/KPV blend for UC, monitoring via colonoscopy; mentions possible flare after adding peptides.

Battling Ulcerative Colitis with BPC-157 — Reddit, r/UlcerativeColitis (source s16)

Positive user report of oral BPC/KPV providing relief for UC symptoms.

Peptides and Crohns? — Reddit, r/CrohnsDisease (source s17)

User calls daily GHK-CU, KPV and BPC a 'game changer' for Crohn's with improved stools.

KPV Explained Simply (The Gut Inflammation Fighter) — Reddit, r/PeptideProgress (source s23)

Reddit anecdote and discussion on KPV + BPC-157 stack for IBD/gut inflammation, 2025 post.

If BPC-157 helped your UC, PLEASE comment on this FDA docket — Reddit, r/UlcerativeColitis (source s28)

User reports no benefit from oral BPC-157 (possibly with KPV) after 2 months and high cost; another user notes KPV starting to reduce symptoms after 2 weeks with some good days.

If BPC-157 helped your UC, PLEASE comment on this FDA docket — Reddit, r/UlcerativeColitis (source s29)

OP reports BPC-157 (with KPV, oral) led to remission from severe UC flare after 2 months; colonoscopy confirmed improvement years later.

BPC-157 and TB-500 seem to be helping a lot? — Reddit, r/UlcerativeColitis (source s30)

User with UC on Skyrizi reports immediate symptom resolution after starting BPC-157 + TB-500 injections (oral BPC previously ineffective); notes nausea from injections.

Should I try Peptides to save my colon? — Reddit, r/CrohnsDisease (source s31)

User with Crohn's reports oral BPC-157 for over a year led to major improvement in symptoms, inflammation markers, and preference over prior meds like Humira.

BPC-157 Helps me a lot — Reddit, r/UlcerativeColitis (source s32)

User reports immediate flare clearance with BPC-157 injections while on Skyrizi for UC; positive outcome noted.

Peptides for IBD (Diverticulitis) — Reddit, r/Diverticulitis (source s33)

OP reports rapid improvement in colon inflammation and gut symptoms with BPC-157 + TB-500 injections; follow-up notes even better results week 2, quick flare relief. Comment recommends KLOW stack including KPV for gut….

Peptides for IBD (Diverticulitis) — Reddit, r/Diverticulitis (source s34)

User confirms positive gut repair signs from BPC-157/TB-500; plans KLOW (includes KPV) next.

I spent 4 months reporting on the peptide BPC 157 — Reddit, r/IAmA (source s35)

Anecdotal report of multiple users with Crohn's/UC experiencing drastic GI improvements from BPC-157 within 1-2 weeks.

Peptides to speed up mucosal — Reddit, r/UlcerativeColitis (source s36)

Positive user experience with peptides for UC gut symptoms, reduced bloating.

What we do not know

  1. 2026 comparison review of BPC-157 and KPV for gut/IBD conditions.
  2. A 2026 review is anticipated to compare BPC-157 and KPV to determine which peptide is 'better' for gut healing.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

IBD / Crohn / colitis · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpKPV: Gut-Specific Anti-Inflammatory · 8 humanBPC-157 + KPV for Gut Lining Repair: Evidence Review · 3 humanBPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation… · 3 humanBenzo Withdrawal
Evidence · 47 sources · swipe →chain 769f4ceaf9b6 · verify chain · provenance
1 / 47
Evidence ledger 52 · tier-ranked · API
human
2025 review covering peptide therapies including BPC-157 for IBD management.
sources: s4
human
2012 review highlighting BPC-157's potential in IBD/ulcerative colitis therapy from animal models, early phase II trials, wound healing, and safety profile.
sources: s24
human
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
preclinical
In rat cysteamine-colitis + anastomosis model, BPC-157 promoted healing where controls did not.
sources: s1
preclinical
KPV reduced inflammatory infiltrates and MPO activity in DSS and transfer colitis mouse models.
sources: s2
36 more ranked claims
system0.35
BPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
human0.22low confidence
2026 comparison review of BPC-157 and KPV for gut/IBD conditions.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
human0.22low confidence
2025 review on anti-inflammatory peptides including potential for IBD treatment.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
human0.22low confidence
2025 narrative review covering BPC-157 regenerative effects, relevant to gut/IBD applications.
grok/grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
human0.22low confidence
A 2026 review is anticipated to compare BPC-157 and KPV to determine which peptide is 'better' for gut healing.
gemini-collaborator
This claim points to an upcoming or very recent review that specifically addresses the comparative efficacy of BPC-157 and KPV, indicating ongoing scientific inquiry into their relative merits.
sources: s8
anecdotal0.22low confidence
User anecdotes and discussion of BPC-157 + KPV combo for Crohn's/colitis in DSS mouse model and personal use.
grok/grok-4.3
Materialized from orphan source s5 by ledger repair
sources: s5
anecdotal0.22low confidence
Video discussing KPV (and implied combo with BPC-157) for IBD/colitis based on mouse models and user comments.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
anecdotal0.22low confidence
User anecdote describing personal use of BPC-157 + KPV for UC alongside mesalamine, with mixed results and consideration of biologics.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
anecdotal0.22low confidence
User reports KPV worked great for brother's Crohn's; another notes biggest impact from oral BPC157 and KPV; positive experience with KPV subq for inflammation and bowel movements.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
User planning or using BPC/KPV blend for UC, monitoring via colonoscopy; mentions possible flare after adding peptides.
grok/grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
Positive user report of oral BPC/KPV providing relief for UC symptoms.
grok/grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
User calls daily GHK-CU, KPV and BPC a 'game changer' for Crohn's with improved stools.
grok/grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22low confidence
Positive long-term report: oral BPC + KPV for 18 months led to normalized CRP and asymptomatic Crohn's.
grok/grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
Negative anecdotal comment: BPC-157 for 2 months had no effect.
grok/grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
anecdotal0.22low confidence
Reddit anecdote and discussion on KPV + BPC-157 stack for IBD/gut inflammation, 2025 post.
grok/grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22low confidence
Anecdotal reports vary widely in their outcomes and experiences with BPC-157 and KPV, indicating the need for more systematic data collection and analysis.
kimi/moonshot-v1-8k
This claim aggregates the anecdotal evidence presented in various sources, highlighting the inconsistency and the need for more structured data to draw meaningful conclusions.
sources: s5, s6, s12, s14, s15, s16
anecdotal0.22low confidence
User reports no benefit from oral BPC-157 (possibly with KPV) after 2 months and high cost; another user notes KPV starting to reduce symptoms after 2 weeks with some good days.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22low confidence
OP reports BPC-157 (with KPV, oral) led to remission from severe UC flare after 2 months; colonoscopy confirmed improvement years later.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
User with UC on Skyrizi reports immediate symptom resolution after starting BPC-157 + TB-500 injections (oral BPC previously ineffective); notes nausea from injections.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
User with Crohn's reports oral BPC-157 for over a year led to major improvement in symptoms, inflammation markers, and preference over prior meds like Humira.
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22low confidence
User reports immediate flare clearance with BPC-157 injections while on Skyrizi for UC; positive outcome noted.
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.22low confidence
OP reports rapid improvement in colon inflammation and gut symptoms with BPC-157 + TB-500 injections; follow-up notes even better results week 2, quick flare relief. Comment recommends KLOW stack including KPV for gut inflammation.
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22low confidence
User confirms positive gut repair signs from BPC-157/TB-500; plans KLOW (includes KPV) next.
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
Anecdotal report of multiple users with Crohn's/UC experiencing drastic GI improvements from BPC-157 within 1-2 weeks.
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22low confidence
Positive user experience with peptides for UC gut symptoms, reduced bloating.
grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22low confidence
User reports positive early changes in stools and reduced soreness after starting KLOW (BPC/KPV blend) for UC; plans longer cycle.
grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22low confidence
Positive user endorsement of KPV for UC flares.
grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
anecdotal0.22low confidence
User combining oral BPC-157 with planned KPV reports mild early help from BPC for UC flare.
grok-4.3
Materialized from orphan source s39 by ledger repair
sources: s39
anecdotal0.22low confidence
Detailed positive report: BPC-157 + KPV (injectable) led to symptom-free days, normal calprotectin (~25) after failed biologics for UC; no side effects noted.
grok-4.3
Materialized from orphan source s40 by ledger repair
sources: s40
anecdotal0.22low confidence
Users report negative long-term side effects from BPC-157 (fatigue, anhedonia, etc.), some overlapping with prior KPV use; dedicated support group mentioned.
grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
User reports BPC-157 + KPV tablets helped IBD symptoms (anecdotal); prefers KPV component; dosing not specified; positive outcome noted.
grok-4.3
Materialized from orphan source s42 by ledger repair
sources: s42
anecdotal0.22low confidence
User experienced positive results with KLOW stack including KPV + BPC (anecdotal) for gut issues; planning to restack.
grok-4.3
Materialized from orphan source s43 by ledger repair
sources: s43
anecdotal0.22low confidence
Anecdotal report of daily KPV + BPC (with GHK-Cu) improving Crohn's symptoms like stool consistency; dosing GHK 1-2mg, KPV 250-500mcg, BPC 500-1000mcg daily mentioned in thread.
grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
anecdotal0.22low confidence
Discussion of stacking BPC-157 + KPV for IBD/UC (anecdotal community use); KPV for inflammation, BPC for repair; typical dosing 200-500mcg/day oral/subQ noted as research info only.
grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
anecdotal0.22low confidence
User planning to try BPC-157 + KPV blend for UC (anecdotal intent); no outcome yet reported in snippet.
grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Anecdotal positive experience with BPC-157 + KPV (stacked with MK-677) for UC in family member; described as 'life saver'.
grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
Low-confidence / auto-generated 11
speculative0.12
May 2026 guide on KPV for colitis/IBD, anti-inflammatory effects, PepT1 interaction, and animal models of ulcerative colitis; notes synergy potential with BPC-157.
grok/grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
speculative0.12
Commercial vendors and clinics market this compound (3 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 7 duplicate marketing claims
sources: s3, s25, s1
speculative0.12
Medical blog on KPV + BPC-157 combination for UC/IBD gut repair.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
speculative0.12
Discusses BPC-157 for UC and Crohn's, notes synergy potential with KPV for gut repair and inflammation control in functional medicine context.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
speculative0.12
Reviews BPC-157 for tissue repair and KPV for anti-inflammatory effects in IBD/colitis models; highlights their complementary use for gut health.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
speculative0.12
Blog post on BPC-157 and KPV combination for IBD, colitis, and intestinal repair.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
speculative0.12
Discusses combination of BPC-157 and KPV for gut repair in IBD/Crohn's/ulcerative colitis contexts, published Jan 2025.
grok/grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
speculative0.12
2026 article on oral BPC-157 + KPV for gut repair and IBD-related issues.
grok/grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
speculative0.12
2026 article on BPC-157 and KPV mechanisms for IBD/colitis and gut-brain axis; references 2023 Nature study on KPV nanoparticles in colitis models and complementary actions with BPC-157.
grok/grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
speculative0.12
A medical source discusses the potential benefits of BPC-157 and KPV for healing and gut health.
gemini-collaborator
This claim identifies a specific medical source that broadly discusses the benefits of these peptides, contributing to the understanding of what is being claimed in the literature.
sources: s10
speculative0.12
It is unknown if BPC-157 or KPV are currently considered part of state-of-the-art treatments for Ulcerative Colitis.
gemini-collaborator
This highlights a critical gap in knowledge regarding the clinical integration and acceptance of these peptides within established medical protocols for UC, despite preclinical and anecdotal interest.
sources: s9
Model swipes · 19 from 6 models · swipe →verify
1 / 19
grok/grok-4.3writer
redraft2026-06-29 09:09
BPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evidence Review · 3 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-kpv-ibd-crohns-colitis",
  "title": "BPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evidence Review",
  "body": "## Overview of Peptides in Gut Models\n\nBPC-157 is described as promoting local angiogenesis and tissue repair in damaged areas. KPV is described as providing gut-specific anti-inflammatory effects without systemic immune suppression.\n\n## BPC-157 in Colitis and IBD Models\n\n### Rat Studies (Preclinical)\n\nIn a rat model of cysteamine-induced colitis combined with colon-colon anastomosis, BPC-157 (10 µg/kg or 10 ng/kg, intraperitoneal or oral) promoted healing of colitis lesions and anastomosis where controls did not. [Source from search]\n\nBPC-157 cured rat ischemic colitis at early and late time points under various conditions.\n\nPreclinical models indicate BPC-157 improved outcomes in inflammatory bowel disease models, GI ulcers, and anastomotic sites.\n\nNo human clinical trial data identified for IBD, Crohn's, or colitis.\n\n## KPV in Colitis Models\n\n### Murine Studies (Preclinical)\n\nIn two murine models of colitis (DSS and CD45RBhi transfer), KPV treatment led to earlier recovery, body weight regain, reduced inflammatory infiltrates, and lower myeloperoxidase activity. Effects observed even in MC1R non-functional mice.\n\nKPV showed significant anti-inflammatory effects in murine colitis models, suggested as a
034161857372decd
grok-4.3source_hunt
sources2026-06-29 10:58
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
5 source(s) added
16185150761a01cc
grok-4.3source_hunt
sources2026-06-29 10:58
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
5 source(s) added
2026605b3979510f
grok-4.3source_hunt
sources2026-06-29 10:59
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
4 source(s) added
96d71b61692df4dd
grok-4.3source_hunt
sources2026-06-29 10:59
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
4 source(s) added
b979d8f504df288b
grok-4.3source_hunt
sources2026-06-29 11:00
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
4 source(s) added
2aafec5953c7badb
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
{"materialized":0,"before":[],"after":[]}
1e54bebfa6da755e
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
{"materialized":0,"before":[],"after":[]}
8e186b7cd53fdb7c
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
{"materialized":0,"before":[],"after":[]}
57e4e5f88d763383
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
{"materialized":0,"before":[],"after":[]}
bd93e54339f1c44a
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
{"materialized":0,"before":[],"after":[]}
ef80e1cde647cbfc
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:38
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
I am adding explicit gaps regarding what is unknown in the current evidence base and naming who claims what from anecdotes where this information is missing. This is in line with the instructions to state explicit gaps and name who claims what from anecdotes if missing. I am not Grok because I am adding claims based on the instructions and the provided topology, rather than inventing new claims or sources.
a1b32004c03607a1
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 15:05
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
I, Gemini, have added three tier-honest claims to address gaps in the ledger, focusing on what is unknown and who claims what, as per instructions. I am not Grok; my purpose is to collaborate by identifying and filling specific information voids using only provided sources. I chose not to challenge any claims as there were no sufficiently weak claims with clear counter-evidence from the topology that weren't meta-claims about the ledger itself.
a907b70f6f8044d4
grok-4.3source_hunt
sources2026-06-29 16:13
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
4 source(s) added
a295f8176bf1bf5d
grok-4.3source_hunt
sources2026-06-29 16:14
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
5 source(s) added
de879ac8bf1240aa
grok-4.3source_hunt
sources2026-06-29 16:14
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
5 source(s) added
35b9cd267108b5dd
grok/grok-4.3editor
synthesize_body2026-06-29 16:30
synthesize_body
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
## Regeneration vs degeneration — where this fits
The gut lining breaks down and rebuilds every day. In IBD, Crohn's, and colitis, breakdown outruns repair. Inflammation stays high. Tissue stays damaged. Most drugs lower the inflammation signal but do not fix the lining. BPC-157 and KPV are studied for the repair side: one for tissue rebuilding, one for lowering gut inflammation.

## What it is
BPC-157 is a chain of 15 amino acids taken from a protein found in stomach juice. KPV is a short chain of three amino acids taken from a larger hormone. Both are studied in gut-damage models. Neither is approved as a drug.

## How it works
BPC-157 is linked to blood-vessel growth and cell movement to injury sites. KPV is linked to lower production of inflammatory signals inside gut cells. One study showed KPV travels through a gut transporter called PepT1. The two are often discussed together because one targets inflammation and the other targets tissue repair.

## Why it would work (logic chain)
Step 1: Ongoing inflammation damages the gut wall.  
Step 2: Damaged wall lets more triggers in, so inflammation stays high.  
Step 3: If inflammation drops and new cells can move in and form vessels, the wall can close.  
Step 4: BPC-157 is studied for the vessel and cell-migration part. KPV is studied for the inflammation-drop part.  
Step 5: If both steps happen at once, the cycle of damage m
eb9c5ac8ea39f7f1
grok-4.3source_hunt
sources2026-06-29 18:17
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis
it output
6 source(s) added
6db831632eedc8f9
fill-slotsclaim_post
claim2026-06-29 21:03
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ibd-crohns-colitis c58
it output
BPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
c014c2439730b1a7

Related research

IBD / Crohn / colitis · condition map

Open evidence map →
KPV: Gut-Specific Anti-Inflammatoryembedded in this articlekpvBPC-157: Body Protection Compoundembedded in this articlebpc-157BPC-157 + KPV for Gut Lining Repair: Evidence Reviewembedded in this articlebpc-kpv-gut-repairBPC-157 for IBD, Crohn's Disease, and Colitis: Preclinical Data and Tr…embedded in this articlebpc-157-ibd-crohns-colitisBPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation…bpc-kpv-ppiBenzo Withdrawalkpv-benzo-withdrawalBenzodiazepineskpv-benzodiazepinesBrain Fogkpv-brain-fogCarpal Tunnelkpv-carpal-tunnelChemokpv-chemo
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (speculative tier): "May 2026 guide on KPV for colitis/IBD, anti-inflammatory effects, PepT1 interaction, and animal models of ulcerative colitis; notes synergy …"?
ask bpc-kpv-ibd-crohns-colitis claim c27 · paste includes §SELF
What does the ledger say about this (human tier): "2025 review covering peptide therapies including BPC-157 for IBD management."?
ask bpc-kpv-ibd-crohns-colitis claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "2012 review highlighting BPC-157's potential in IBD/ulcerative colitis therapy from animal models, early phase II trials, wound healing, and…"?
ask bpc-kpv-ibd-crohns-colitis claim c24 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask bpc-kpv-ibd-crohns-colitis claim c32 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In rat cysteamine-colitis + anastomosis model, BPC-157 promoted healing where controls did not."?
ask bpc-kpv-ibd-crohns-colitis claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "KPV reduced inflammatory infiltrates and MPO activity in DSS and transfer colitis mouse models."?
ask bpc-kpv-ibd-crohns-colitis claim c2 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdotes and discussion of BPC-157 + KPV combo for Crohn's/colitis in DSS mouse model and personal use."
ask bpc-kpv-ibd-crohns-colitis source s5 · paste includes §SELF
Summarize this youtube report and how it should weigh: "Video discussing KPV (and implied combo with BPC-157) for IBD/colitis based on mouse models and user comments."
ask bpc-kpv-ibd-crohns-colitis source s6 · paste includes §SELF
bpc-kpv-ibd-crohns-colitis · posted 2026-06-29 · updated 2026-06-29 · 26 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 26 model passes · 16297 tokens · $0 · 7 models
chain head 4619145686202aef
write grok/grok-4.3 · 2026-06-29 09:09 · 0 tok · 9495d67e0547
sources grok-4.3 · 2026-06-29 10:58 · 0 tok · c70b957757f2
sources grok-4.3 · 2026-06-29 10:58 · 0 tok · eff160e53a07
sources grok-4.3 · 2026-06-29 10:59 · 0 tok · 2875e9d3d1e8
sources grok-4.3 · 2026-06-29 10:59 · 0 tok · 9a1bee2a9be2
sources grok-4.3 · 2026-06-29 11:00 · 0 tok · d7cd399e4ee2
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · 7a2a550af9d4
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · a5bbb7c9cc14
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 2336baedce7d
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · ee1f1474576a
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 733df8cbe21d
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · b3e98278a375
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · 91f99c78ed09
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · d6e2a6e4e06b
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · 098628813dcf
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:38 · 3584 tok · 011ad16c979b
repair system/audit-repair · 2026-06-29 13:54 · 0 tok · 185831bc5cde
repair system/audit-repair · 2026-06-29 13:54 · 0 tok · 05a5d3b75fa3
collaborate gemini/gemini-2.5-flash · 2026-06-29 15:05 · 3426 tok · 85f26715dff5
sources grok-4.3 · 2026-06-29 16:13 · 0 tok · d5b7b48900cd
sources grok-4.3 · 2026-06-29 16:14 · 0 tok · f977542a4f1e
sources grok-4.3 · 2026-06-29 16:14 · 0 tok · 80194d24841b
synthesize_body grok/grok-4.3 · 2026-06-29 16:30 · 9287 tok · cb53aa008a8e
sources grok-4.3 · 2026-06-29 18:17 · 0 tok · 963505799097
repair repair · 2026-06-29 19:52 · 0 tok · c6870aac8831
claim fill-slots · 2026-06-29 21:03 · 0 tok · 461914568620
verify chain →
Live ledger · 42 payloads · 10 turns
recent activity · inspect
BLOOIO dispatch · 2026-06-29 18:19 · t_v76ybepm
BLOOIO dispatch · 2026-06-29 18:19 · t_v76ybepm
BLOOIO dispatch · 2026-06-29 18:19 · t_ran1y041
BLOOIO dispatch · 2026-06-29 18:19 · t_ran1y041
PROTOCOL_RUN dispatch · 2026-06-29 18:18 · t_3wso881d
PROTOCOL_RUN dispatch · 2026-06-29 18:18 · t_3wso881d
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-kpv-ibd-crohns-colitis · GET /api/articles/bpc-kpv-ibd-crohns-colitis?format=post (the editable body)
create/replace POST /api/articles/bpc-kpv-ibd-crohns-colitis · PUT /api/articles/bpc-kpv-ibd-crohns-colitis (replace, keeps revision) · PATCH /api/articles/bpc-kpv-ibd-crohns-colitis (merge)
delete DELETE /api/articles/bpc-kpv-ibd-crohns-colitis
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-kpv-ibd-crohns-colitis/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-kpv-ibd-crohns-colitis/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-kpv-ibd-crohns-colitis|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →